Recurrent Increased Nuchal Translucency Led to the Identification of Novel NUP107 Variants.

Abstract excerpt

Five percent of fetuses presents increased fetal nuchal translucency. It is a well-known marker for aneuploidy (T21, Turner syndrome) and a variety of monogenic syndromes such as Noonan syndrome and certain skeletal dysplasias, as well as associated with structural malformations such as congenital heart disease. Current diagnostic algorithms for increased nuchal translucency include a rapid test for aneuploidy...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Aneuploidy
• Share to Exome Sequencing